glp 1 optic nerve GLP-1 Medications and NAION: What Patients Should Know About Sudden Vision Loss Ozempic Blindness: Should You Worry?

Data was self-reported by 1,671 surveyed customers who checked in with their provider on their second check-in between 4/7/22 and 2/9/26

For many patients, these symptoms gradually improve over several weeks as the body adapts, though the timeline varies individually and some people may experience persistent symptoms requiring management strategies

Thats the idea at least

A 2025 IV safety study (Lee & Burgess, Alternative Therapies / PubMed) administered up to 20 mg IV in healthy adults with no adverse events recorded across cardiac, hepatic, renal, and thyroid biomarkers

If left unaddressed, then the oxidative stress that ROS causes can actually kill cells